U.S.-listed shares of Canadian cannabis companies rallied anew Wednesday, as analysts cheered the latest link-ups in the sector and remained bullish on a market expected to […]
The U.S. Food and Drug Administration’s recent historic approval of a plant-derived epilepsy drug whose main ingredient is cannabidiol (CBD) points to sweeping changes ahead for […]
Marijuana-related stocks rampaged higher Tuesday, after Cronos Group Inc. detailed an agreement that seeks to extract key compounds from cannabis for medicinal purposes. Canadian cannabis company […]
“International Legal Marijuana Market Research Report 2018” liable for its analysis which furnishes an overall assessment of Legal Marijuana market including sales and evolving business sectors. […]
A cannabis initiative team at UCLA plans to conduct a high-quality clinical study of the painkilling properties of pot — and perhaps stem the opioid epidemic. […]
 FIRSTNAME LASTNAME parkker Week in Review 8/27-8/30 2018 week in review vista green llc […]
